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Abstract
Background: To evaluate the compliance, benefits and side effects associated with continuous positive airway
pressure (CPAP) therapy among Pakistani patients treated for obstructive sleep apnea (OSA) in private sector.
Methods: Patients diagnosed to have OSA based on overnight study who were recommended for CPAP therapy,
between 1998 and 2003, were evaluated by telephonic survey and review of hospital notes. Compliance, benefits
and side effects associated with CPAP therapy were assessed.
Results: Out of 135 patients who were prescribed CPAP therapy, 75 could be contacted. Sixty (80%) started using
CPAP within one month of diagnosis and 46 (61%) continued to use it long-term (beyond one year). Compliance
with CPAP therapy was associated with higher body mass index, higher Epworth sleepiness scale score, history of
witnessed apnea, and reduction in daytime sleepiness with CPAP therapy. OSA severity as assessed by apnea-hypopnea
index did not affect compliance with CPAP therapy. Use of anti-depressants and CPAP induced sleep disturbances were
associated with poor compliance with CPAP therapy.
Conclusions: Obesity, excessive daytime sleepiness, witnessed apnea and improvement of daytime symptoms
following use of CPAP were predictors of improved compliance. Use of antidepressants and CPAP induced sleep
disturbances were predictors of poor compliance.
Keywords: Obstructive sleep apnea, Continuous positive airway pressure therapy, Compliance, Side effects, Pakistan

Background
Obstructive sleep apnea (OSA) is relatively common disorder with estimated prevalence of 4% in men and 2% in
women [1]. OSA is characterized by intermittent obstruction of the upper airway during sleep. Patients experience
repetitive episodes of apnea (complete cessation of airflow),
hypopnea (partial reduction in airflow) and oxygen desaturation, and sleep fragmentation. Common symptoms are
of loud habitual snoring, frequent nocturnal awakening,
unrefreshing sleep and excessive daytime sleepiness (EDS).
Age, gender, obesity, and nasal blockage are some of the
well-established risk factors for OSA [2]. OSA is associated
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with poor sleep quality, impaired cognition and increased
risk of accidents [3]. Furthermore, there is increased risk of
fatal and non-fatal cardiovascular events and the treatment
of OSA favorably reduces the risks associated with OSA
[4]. Similarly, OSA is associated with an increase in blood
pressure that is improved with treating apnea but not by
supplemental O2 therapy suggesting mechanisms other
than hypoxemia are responsible for hypertension [5].
Continuous positive airway pressure (CPAP) therapy is
the treatment of choice for OSA. CPAP therapy produces
improvements in daytime sleepiness and cognitive function with improved quality of life compared with control
[6]. Good compliance with CPAP therapy has been shown
to achieve cardiovascular and metabolic benefits [7].
Despite the high efficacy of CPAP, treatment effectiveness is limited by variable adherence to prescribed therapy
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[8]. Failure to comply with CPAP therapy may occur in up
to 25% to 50% patients, with patients typically abandoning
therapy within the first 4 weeks of treatment [9]. In one
review up to 91% of the patients discontinued the CPAP
treatment in the first three years of therapy [10].
The aim of this study was to evaluate the compliance,
benefits and side effects associated with CPAP therapy
among Pakistani patients treated in private sector.

Methods
The study was conducted at The Aga Khan University
Hospital, a private teaching hospital in Karachi, Pakistan.
Patients were diagnosed to have OSA based on suggestive clinical features (habitual snoring, witnessed apnea,
unrefreshing sleep and excessive daytime sleepiness)
and confirmed by an overnight-supervised oximetry or
polysomnography. Two levels of sleep studies were performed; overnight full polysomnography in 55 (73.3%)
and overnight pulse oximetry in 20 (26.7%) patients.
The variables monitored in polysomnography were electroencephalogram (EEG), electrooculogram (EOG), chin and
leg electromyogram (EMG), electrocardiogram (ECG),
oronasal airflow (thermistor), oxygen saturation, and
chest and abdominal wall movements (respiratory inductive plethysmograph). In overnight oximetry data
was analysed for number of Oxygen (O2) desaturations,
basal O2 saturation, minimum O2 saturation, cumulative time spent below 90% saturation and O2 desaturation index (total number of O2 desaturation divided by
duration of recording in hrs). Waveform was recorded
for the whole duration of recording as a compact onepage tracing and in an expanded hourly format for detailed review. Daytime sleepiness was assessed using
Epworth sleepiness scale (ESS) score [11]. Threshold
for treating OSA was apnea-hypopnea index (AHI) > 15
per hour or 3% oxygen desaturation index > 15 per hour
accompanied with daytime symptoms. Nasal CPAP was
initiated following a supervised titration study. Patients
had a session on mask application and machine use.
The patients had to buy their own machine.
The survey was done from January to March 2006.
Patients diagnosed to have OSA between 1998 and
2003 were included in the study. A trained research officer
reviewed their notes and contacted patients by telephone.
As this was the telephonic survey, verbal consent was
taken from all participants. Data was entered using a
structured questionnaire that elicited information about
symptoms, past medical history, drug history, family history, sleep history, examination findings and results of investigations. Compliance was assessed by asking multiple
questions on daily day time and night time usage in hours
and period of failure to use of CPAP machine. Benefits
and side effects associated with CPAP therapy were also
assessed.
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Improvement in ESS score of two points or more was
considered significant. Compliance was defined as continued (long-term) use of CPAP therapy beyond one
year. Current smoker was defined as someone who continues to smoke any amount of tobacco either regularly or
occasionally. A non-smoker was one who has never
smoked and an ex-smoker was someone who had smoked
in the past but had now stopped.
The study was approved by Ethics Review Committee
(ERC) of Aga Khan University.
Statistical analysis

The Statistical Package for social science SPSS version
16.0 was used for data analysis. Descriptive analysis was
done for demographic, clinical and radiographic features.
Results were expressed as mean ± standard deviation for
quantitative variables and number (percentage) for qualitative variables. In Univariate analysis difference in means
for compliance and non-compliance were performed by
Independent Sample t-test, where as difference in proportion were assessed by Pearson Chi-square or Fisher’s exact
test where were appropriate. P value less than 0.05 was
considered as statistically significant. All p-value were two
sided.

Results
A total of 135 patients were diagnosed to have OSA between 1998 and 2003. At the time of survey, 75 (55.5%)
patients (60 males) had a valid contact detail and were
contacted. The base line characteristics of patients of
OSA with and without valid contact is presented in
Table 1.
Out of 75 patients who had a valid contact, continuous
positive airway pressure therapy was started by 60 (80%)
patients within one month of prescription and 46 (61.3%)
continued to use CPAP therapy beyond one year. 56/75
(75%) patients used the machine for over 5 hours each
night. CPAP was perceived as a satisfactory treatment by
50 (67%), not satisfactory by 7 (9%) while 18 (24%) were
not sure about it. Subjective improvement in snoring was
reported by 51 (68%) and in daytime performance by 54
(72%). Objective improvement in Epworth sleepiness scale
score was recorded in 54 (72%).
Side effects associated with CPAP therapy were minor
but frequent. These included skin changes in 31 (41%),
sleep disturbance in 19 (25%), poor mask fit in 15 (20%),
eye irritation in 13 (17%), ear symptoms in 9 (12%) and
flatulence in 10 (13%).
Factors associated with compliance

On univariate analysis age, gender, history of snoring, presence of comorbid conditions or smoking status, mask related side effects, OSA severity (as assessed by AHI index)
did not affect compliance with CPAP therapy. However,
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Table 1 The base line characteristics of patients of
Obstructive sleep apnea with and without valid contact
Characteristics

Valid contact Without valid
P-value
(n = 75)
contact (n = 60)

Table 2 Factors associated with compliance with CPAP
therapy beyond one year in Pakistani patients on
univariate analysis
Factors

Sex:
Male

60 (80%)

49 (82%)

Female

15 (20%)

11 (18%)

Age (mean) ± SD years

52.9 ± 12.1

BMI
Collar size (cm)
ESS

Compliant Non-Compliant p-value
(n = 46)

(n = 29)

38.2 ± 11.9

31.7 ± 6.5

0.83

Affecting increasing
compliance with

50.23 ± 14.0

0.41

CPAP therapy

35.89 ± 10.75

36.4 ± 8.23

0.86

BMI (kg/m2)

35.9 ± 14.4

35.1 ± 11.7

0.9

ESS score before CPAP

17.5 ± 4.1

12.6 ± 6.7

0.005

0.87

Witnessed apnea before CPAP

33 (72%)

7 (30%)

0.001

Improved daytime activity
with CPAP

43 (94%)

11 (73%)

0.05

ESS score improved with CPAP 43 (94%)

11 (73%)

0.05

10 (67%)

0.001

15.8 ± 5.6

15.2 ± 8.4

Smoking status:
Current smoker

16 (21%)

18 (30%)

Ex-smoker

19 (25%)

16 (27%)

Non smoker

40 (54%)

26 (43%)

Hypertension

42 (57%)

21 (35%)

0.01

Diabetes

21 (28%)

18 (30%)

0.85

Ischemic heart disease

20 (27%)

14 (23%)

0.69

Dyslipidemia

10 (14%)

13 (21%)

0.25

COPD

08 (11%)

10 (16%)

0.32

History of nasal surgery

11 (15%)

08 (13%)

0.99

0.42

Associated comorbidities

Affecting non-compliance
with CPAP therapy
Sleep disturbance with CPAP

BMI = body mass index, ESS = Epworth sleepiness scale, COPD = chronic
obstructive pulmonary disease.

higher body mass index, higher ESS score at baseline,
higher prevalence of witnessed apnea, improvements in
daytime activity and improvement in ESS score were positively associated with compliance with CPAP therapy,
while CPAP induced sleep disturbance was associated with
non-compliance with CPAP therapy (Table 2).

Discussion
Privately paying Pakistani patients who had a valid contact (75/135) at the time of study with obstructive sleep
apnea had 80% (60/75) initial acceptance of CPAP therapy and 61.3% (46/75) continued to use CPAP therapy
beyond one year. This initial compliance rate was similar
to that reported in western studies [12]. Long-term compliance with CPAP therapy varied between countries,
lower compliance rates were reported in North America
compared to Europe [12].
Studies on CPAP compliance in ethnic groups are limited. In a Chinese study, 33% never commenced CPAP
therapy [13]. Even lower compliance rate (36%) was observed among bus drivers in Hong Kong despite significant improvement in subjective sleepiness and cognitive
function with CPAP therapy [14]. In a study from USA,
CPAP adherence was low in black subjects [15]. Similarly Maori subjects had lower adherence to CPAP therapy than Maori subjects that was thought to be related

0.015

9 (20%)

BMI = body mass index, CPAP = continuous positive airway pressure,
ESS = Epworth sleepiness scale.

to lower educational levels and socioeconomic status
[16]. Thus, differences in compliance with CPAP therapy
were multifactorial such as ethnicity, educational and socioeconomic status, and differences in treatment facilities and follow-up.
Differences in compliance may occur in patients being
treated in private and public sectors. This aspect of
CPAP therapy has not been studied in detail. In a study
from Brazil [17], patients in private sector had more
greater severity of OSA than patients in public sector
(AHI 31 ± 25 vs. 25 ± 24, p < 0.001) but CPAP acceptance
was similar in both sectors (32 vs. 35%). This acceptance
rate was much lower than that observed in our cohort of
private sector patients as well. In Pakistan the health
care facilities in public sector are suboptimal and inadequate resources are available to provide top quality
healthcare provision. The peoples who seek these facilities are mainly from low socio-economic groups. The
sleep study facilities were not available in most of the
public sector hospitals of Pakistan at the time of study
and they referred all these patients to private sector hospitals. When we did this study not a single public sector
hospital offer diagnosis and treatment facility in the city.
This is one of the major reason and a limitation that we
are unable to compare our cohort with public sector
cohort.
In our study the long-term compliance with CPAP
therapy was 61% among all OSA patients but 76%
among those who initially accepted CPAP. In a study
from UK, 77% were still using CPAP at three years and
median use of CPAP in those continuing therapy was
5.3 hours/night [18]. In another UK-based study of over
1000 OSA patients, 4.5% patients refused CPAP treatment

Hussain et al. BMC Pulmonary Medicine 2014, 14:188
http://www.biomedcentral.com/1471-2466/14/188

(these were more often female and current smokers) and
during follow-up 20% stopped treatment, primarily because of a lack of benefit. Methods of survival analysis
showed that 68% of patients continued treatment at 5 year
[19]. The compliance was higher (86%) among those with
severe OSA (AHI > 30/hr) accompanied with daytime
sleepiness. Among a cohort of 109 German patients
treated with CPAP, only 46.6% met stringent criteria for
long-term compliance, defined as a mean use of the CPAP
machine for at least 5 hours per night [20]. In Canada,
using a population-based CPAP program consisting of
consistent follow-up, “troubleshooting”, and regular feedback to both patients and physicians CPAP compliance
rates of greater than 85% over 6 months was achieved
[21]. In our set up, choice of nasal interface was limited,
patients often had to travel long distances and the onus of
follow-up remained with the patient. Despite these limitations a long-term compliance of above 60% was seen.
Factors associated with compliance with CPAP therapy
are manifold. These include patient characteristics, symptoms, psychological factors, sleep study variables, response
to therapy, side effects, cost of treatment, expertise available, and use of interventions and educational strategies
to improve compliance with treatment. In our study, OSA
severity as assessed by AHI did not correlate with a better
compliance. Similar findings were reported from USA and
UK, in which long-term compliance was not associated
with AHI severity but with daytime symptoms [22] or
negatively with side effects associated with CPAP therapy
[23]. However, other studies have shown a positive association between compliance and severity of OSA as assessed
by AHI [24,25]. Age and gender were not associated with
compliance with CPAP therapy in our study, and variable
results have been reported in literature [21,25].
In our study use of anti-depressant was associated
poor compliance with CPAP therapy. This was in keeping with other studies showing that psychological factors
contributed partly to compliance with therapy [26]. High
anxiety and depression score were associated with poor
compliance with CPAP therapy [27]. Recent life-events
and living alone were also associated with lower machine
use [28].
Patients who experience side effects from CPAP machine are less likely to comply with therapy but the nature of side effects that impacts compliance have varied
between studies [21,23,25]. In our study, sleep disturbance associated with the use of CPAP therapy was
strongly associated with poor compliance with therapy.
In our study, long-term compliance with CPAP therapy was better in those patients who achieved an improvement in daytime symptoms. CPAP therapy was
perceived as an effective treatment by majority (67%) of
our patients, similar to finding from Toronto study
where 81% perceived CPAP as an effective treatment
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[29]. Improvement in ESS score was associated with better compliance in one study [21], but improvement in
multiple sleep latency in another study was not associated with higher CPAP usage [23].
There are certain limitations of our study. First there
is a small sample size and we have only valid contact of
75 out of 135 patients. The most important reason for
this level of dropout is that most of the patients give
their cell phone numbers for contact and there is a very
common practice and habit of our population that they
change their cell phone numbers and services very frequently. As this is a single center study and most of the
patients with and without valid contact are from the
same background so that we can assume that the level
of withdrawal would also be same in patients without a
valid contact. Second we use telephone survey to assess
the compliance of CPAP therapy. We know that there
are some problems for precise evaluation for this
method and now newer CPAP machine has built-incapabilities of keeping record of day and night usage.
During the study period these types of machines were
not available in Pakistan and almost all of the patients
use machines without these facilities. We try to overcome this shortcoming by asking multiple questions on
compliance by using a preformed detailed structured
questionnaire. Future studies using records of CPAP machine would be more reliable regarding compliance of
CPAP usage. We use only univariate analysis with a
small sample size is another limitation and studies with
larger sample size with logistic regression analysis would
be more helpful.

Conclusion
In conclusion, privately paying Pakistani patients were able
to achieve similar level of compliance with CPAP therapy
as in other countries. Severity of OSA symptoms at presentation and benefit from treatment predicted higher compliance with CPAP therapy. Severity of OSA as assessed by
sleep study did not affect compliance with therapy.
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